•   
  •   
  •   

Sport Analyst: Selloff was a mistake on this "virus" share

05:30  30 september  2020
05:30  30 september  2020 Source:   finanzen.net

Erika Jayne Sounds Off on Denise Richards Leaving RHOBH

  Erika Jayne Sounds Off on Denise Richards Leaving RHOBH Hear what The Real Housewives of Beverly Hills' Erika Jayne had to say on Daily Pop about Denise Richards' exit, the explosive three-part reunion & her dream cast mate.Carrie Underwood and Thomas Rhett Make 2020 ACM Awards History By Tying for Entertainer of the Year

Share this article. Here’s what other analysts and traders said about the selloff : “Technology seems to be caught in a whirlwind of negative news at the moment,” said Peter Jankovskis, co-chief investment officer at Oakbrook Investments.

Share . Tweet. Yahoo Finance's Seana Smith, Myles Udland, Ethan Wolff-Mann and Julia La Roche discuss President Trump's comments on the market selloff , today's rebound, and the impact of rising rates.

The shares of the US vaccine manufacturer Novavax have been badly damaged in recent weeks. But Mayank Mamtani, an analyst at B. Riley FBR, is still convinced of the stock and assumes that the price will more than double.

KAZUHIRO NOGI/AFP/GettyImages © Provided by Finanz.net KAZUHIRO NOGI / AFP / GettyImages

• Still "Buy" for Novavax

• Price doubling expected

• Focus on production capacity for vaccine

The US biotech company Novavax is currently testing its experimental coronavirus vaccine NVX- CoV2373 on test subjects. These tests are even subsidized by the US government as part of the "Operation Warp Speed" project with 1.6 billion dollars. Donald Trump is thus supporting the fight against COVID-19.

Lady Gaga Dazzles in Behind-the-Scenes Snaps From the Valentino Campaign

  Lady Gaga Dazzles in Behind-the-Scenes Snaps From the Valentino Campaign Lady Gaga is an otherworldly goddess in the Valentino Voce Viva fragrance campaign — and Us Weekly got an exclusive behind-the-scenes look! Lady Gaga’s Wildest Fashion and Beauty Looks of All Time Read article On Thursday, September 17, the design house dropped the stunning campaign video, which features the Oscar winner appearing radiant and stunning in a red gown from Valentino’s Beijing couture show in 2019 designed by artistic director Pierpaolo Piccioli. “I felt strong and alive, hearing myself echo through the forest as I was singing in this dress,” she said in a statement from the brand “It reminded me of my freedom and how I get to experience magic, a freedom and magic I wish everyone to have.” The 34-year-old’s subtly beautiful makeup was done by Sarah Tanno and her iconic platinum strands were styled by Frédéric Aspiras. Gwyneth Paltrow, Naomi Campbell and More Star in Valentino’s Fall 2020 Campaign Shot at Home During the COVID-19 Pandemic Read article The dazzling film directed by Harmony Korin aims to spread an inclusive message, encouraging viewers to use their voice for good. “I believe most voices have the ability to positively impact,” says Gaga. “But all voices are impactful.” The “Rain on Me” singer has been a longtime fan of the brand. She’s worn Piccioli’s designs time and time again, including the show-stopping periwinkle number at the 2019 Golden Globe Awards as well as a silver sequin ensemble at this year’s VMAs.

Shares of Altria Group rallied Monday, to extend their bounce off a more than 4-year low, after analyst Bonnie Herzog at Wells Fargo said the selloff was The selloff accelerated last week, after Morgan Stanley downgraded the stock to a rare underweight rating, citing concerns over shifting demographic

Pinterest shares plunged after the company posted a wider-than-expected loss and issued weak guidance in its first quarterly report. Yahoo Finance’s Seana Smith breaks down the report with Ali Mogharabi, Morningstar Analyst , and Mark Zgutowicz, Rosenblatt Securities Analyst .

However, it currently appears that Novavax's vaccine candidate won't be the first to hit the market. At the very least, various competitors are significantly further in their clinical studies. This is likely to be partly responsible for the fact that the share price has recently plummeted. The stock has lost nearly half of its value since its high of $ 189.40 in early August.

Novavax another "Buy"

Nevertheless, Mayank Mamtani, an analyst at B. Riley FBR, is still convinced of the biotech company's prospects for success and believes the recent sell-off is a mistake. According to "Yahoo Finance" he is firm on his "Buy" recommendation and his target price of 257 dollars. If he was right, it would mean more than doubling the share price.

Major study says the coronavirus mutated to become even more dangerous

  Major study says the coronavirus mutated to become even more dangerous A massive study from Houston details a coronavirus mutation that makes the virus more infectious than other strains. This may sound like a scary development for an illness that's already terrifying, but the research details the same dominant mutation that other scientists have already been observing for quite some time. Called D614G, the tiny genetic change affects the spike protein the virus uses to infect cells in the human body. A virus might not have a mind of its own, but like any living thing, it tries to survive at all costs. To do so, it seeks out suitable hosts and then replicates itself using cells in the body.

The virus has already killed almost 3,500 people while infecting more than 100,000 in the world, demonstrating a 3.5 percent mortality rate. It also depends on the particular strain of the virus a person gets infected with. “Everything depends on where you got the virus ,” Favorov explains.

Alarm bells went off about what this might mean for the new Scottish football season. But this “cluster” was a mirage. For any particular individual, the chances of the test being a false positive is small. But when we look at the big picture, we could easily be fooled into thinking that there are many more

Mamtani believes that NVX-CoV2373 will be among the first six of the "first wave" of vaccines against the pathogen Sars-CoV-2 and will prove to be superior in terms of immunogenicity and reactogenicity. In addition, the vaccine can simply be stored in the refrigerator at +2 to +8 degrees Celsius, whereas "mRNA constructs" often require extremely low storage temperatures of down to -80 degrees Celsius.

Production capacity in focus

However, in the opinion of the analyst, there is another weighty argument in favor of Novavax shares. The vaccine manufacturer recently agreed to cooperate with the Indian Serum Institute of India Private Limited (SIIPL), the world's largest vaccine producer. Novavax has thus roughly doubled its production capacity to around two billion cans per year.

This is of great importance because large amounts of vaccine doses are required very quickly. Mamtani points out that most corona vaccine candidates will need to be given twice to be fully effective. With a world population of currently around 7.8 billion people, over 15 billion doses would be required in the short term. The need could be even greater if vaccinations may need to be boosted at regular intervals to maintain immunity.

Mayank Mamtani is convinced that there is currently by far not enough production capacity - even taking into account the vaccine candidates of other companies - to meet this global demand. From an investor's point of view, it is not necessarily a bad thing that demand will exceed supply at least until mid-2021. Eventually, this would give Novavax some power in setting prices. And this power could even last longer if it turns out that the vaccinations have to be renewed at certain time intervals.Redaktion finanzen.net

NFL Power Rankings entering Week 6 .
NFL Power Rankings entering Week 6

usr: 0
This is interesting!